New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 28, 2014
12:42 EDTDANOY, HSPHospira, Danone rise following report of deal talks
Hospira (HSP) and Danone (DANOY) are both climbing after The Financial Times reported that Hospira is in talks about acquiring Danone's medical nutrition business. Meanwhile, Wells Fargo estimated that the deal could be 20%-22% accretive to Hospira's EPS. WHAT'S NEW: French consumer products company Danone is in talks about selling its medical nutrition business to injectable drug maker Hospira, The Financial Times reported yesterday, citing multiple unnamed sources. In the wake of the deal, Hospira could move its tax base to Europe and potentially reduce its tax bill, the newspaper reported. ANALYST REACTION: In a note to investors today, Wells Fargo indicated that it "wouldn't be surprised" if Hospira made the deal. The transaction could raise Hospira's earnings per share by 9%-12% in 2015-2017, excluding operational synergies, if the transaction is carried out in all stock, the firm estimated. If the deal is done in 50% stock and 50% cash, Hospira's EPS could get a 20%-22% boost, excluding operational synergies, the firm estimated. Wells calculated that Hospira's tax bill would be cut to 21% in 2015 and 19% afterwards, from the firm's current forecast of tax rates ranging from 24%-26% from 2015-2017. However, Wells Fargo indicated that it did not see a clear strategic rationale for the deal from Hospira's perspective. It kept a Market Perform rating on the stock. PRICE ACTION: In early afternoon trading, Hospira rose 1.7% to $52.62 and Danone shares trading in New York added nearly 1% to $15.
News For HSP;DANOY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 26, 2014
06:29 EDTDANOYDanone considering sale of Yakult stake, Bloomberg reports
Danone (DANOY) is contemplating the sale of its 20% stake in Japanese dairy-drink producer Yakult Honsha, Bloomberg reports, citing people familiar with the matter. The stake is worth about $2B, Bloomberg adds. Reference Link
November 19, 2014
14:11 EDTDANOYFresenius, Permira made joint bid for Danone nutrition unit, WSJ reports
Fresenius SE, the German parent company of Fresenius Medical (FMS), and buyout firm Permira made a joint bid for Danone’s (DANOY) medical nutrition business, according to The Wall Street Journal, citing people familiar with the matter. Danone has set early next week as the deadline for others to bid, though one of the people said the joint bid is currently the only one on the table, the report noted. Reference Link
13:47 EDTDANOYFresenius, Permira made joint bid for Danone nutrition unit, DJ reports
Subscribe for More Information
November 17, 2014
07:21 EDTDANOY, HSPDanone mulls IPO for nutrition unit as sale talks disappoint, Reuters says
Subscribe for More Information
November 14, 2014
07:14 EDTHSPAmerican College of Rheumatology is holding a meeting
2014 ACR/ARHP Annual Meeting is being held in Boston on November 14-19.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use